Spruce Biosciences (SPRB) News Today → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free SPRB Stock Alerts $0.85 +0.00 (+0.39%) (As of 11:07 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSpruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meetingfinance.yahoo.com - April 30 at 7:33 PMSpruce Biosciences Inc (SPRB)investing.com - April 26 at 10:14 PMSpruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meetingbusinesswire.com - April 22 at 4:05 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRBprnewswire.com - April 4 at 7:15 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRBprnewswire.com - March 27 at 5:36 PMRevenue Downgrade: Here's What Analysts Forecast For Spruce Biosciences, Inc. (NASDAQ:SPRB)finance.yahoo.com - March 23 at 10:38 AMHoldings A/S Novo Sells 359,979 Shares of Spruce Biosciences, Inc. (NASDAQ:SPRB) Stockinsidertrades.com - March 22 at 6:24 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRBprnewswire.com - March 19 at 5:25 PMSpruce Biosciences, Inc. (NASDAQ:SPRB) Major Shareholder Holdings A/S Novo Sells 1,912,316 Sharesinsidertrades.com - March 19 at 4:41 AMSpruce Biosciences, Inc. (NASDAQ:SPRB) Just Reported Earnings, And Analysts Cut Their Target Pricefinance.yahoo.com - March 16 at 9:21 AMSpruce Biosciences (NASDAQ:SPRB) Stock Rating Lowered by Leerink Partnrsmarketbeat.com - March 15 at 6:38 AMSpruce Biosciences Shares Dive 74% After Terminating Genetic Disease Study, Cutting Staffmarketwatch.com - March 14 at 5:54 PMSpruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefallmarkets.businessinsider.com - March 14 at 5:54 PMSpruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoingsbusinesswire.com - March 14 at 3:47 PMStocks to Watch: Spruce Biosciences, UiPathmarketwatch.com - March 14 at 12:53 PMSpruce Biosciences FY23 Loss Widens, CAHmelia-203 Study Fails; Stock Down In Pre-marketmarkets.businessinsider.com - March 14 at 12:53 PMWhy Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday?msn.com - March 14 at 12:53 PMSpruce Biosciences (NASDAQ:SPRB) Downgraded by Guggenheimmarketbeat.com - March 14 at 8:38 AMWhy Is Spruce Biosciences (SPRB) Stock Down 78% Today?investorplace.com - March 14 at 8:28 AMBuy Rating Affirmed for Spruce Biosciences Amid Clinical Trial Optimism and Advancing Dose Cohortsmarkets.businessinsider.com - March 14 at 7:53 AMSpruce Biosciences stock craters 75% on failed Phase 2 studymsn.com - March 13 at 9:51 PMSpruce Biosciences Inc (SPRB) Reports Full Year 2023 Financial Results Amid Clinical Trial Setbacksfinance.yahoo.com - March 13 at 9:51 PMmarketbeat.com - March 13 at 4:11 PMSpruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updatesbusinesswire.com - March 13 at 4:08 PMSpruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAHbusinesswire.com - March 13 at 4:01 PMSpruce Biosciences (SPRB) to Release Earnings on Thursdaymarketbeat.com - March 13 at 7:39 AMSpruce Biosciences' (SPRB) Outperform Rating Reiterated at Royal Bank of Canadamarketbeat.com - March 5 at 10:41 AMArmistice Capital LLC Cuts Stake in Spruce Biosciences, Inc. (NASDAQ:SPRB)marketbeat.com - March 3 at 10:50 AMSpruce Biosciences (NASDAQ:SPRB) PT Raised to $9.00 at Royal Bank of Canadamarketbeat.com - February 26 at 11:20 AMSpruce Biosciences Stock (NASDAQ:SPRB), Short Interest Reportbenzinga.com - February 23 at 2:56 AMGuggenheim starts Spruce Biosciences at buy, cites near-term catalystsmsn.com - February 21 at 5:45 PMGuggenheim Initiates Coverage of Spruce Biosciences (SPRB) with Buy Recommendationmsn.com - February 21 at 5:45 PMAIGH Capital Management LLC Has $2.74 Million Holdings in Spruce Biosciences, Inc. (NASDAQ:SPRB)marketbeat.com - February 16 at 12:21 PMSpruce Biosciences, Inc. (NASDAQ:SPRB) Receives Consensus Recommendation of "Buy" from Analystsmarketbeat.com - February 5 at 3:20 AMSpruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - January 30 at 7:00 PMSpruce Biosciences, Inc. (NASDAQ:SPRB) Short Interest Down 74.4% in Januarymarketbeat.com - January 25 at 12:31 PMSpruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasiafinance.yahoo.com - January 22 at 12:46 PMSpruce Biosciences, Inc. (NASDAQ:SPRB) Sees Significant Increase in Short Interestmarketbeat.com - January 12 at 12:19 PMBuy Rating Affirmed for Spruce Biosciences Amid Positive Clinical Trials and Market Potential for Tildacerfontmarkets.businessinsider.com - January 5 at 9:58 PMSpruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAHfinance.yahoo.com - January 5 at 11:55 AMSpruce Biosciences Provides Clinical Program Updates and Outlook for 2024finance.yahoo.com - January 4 at 12:43 PMBuy Rating Justified by Promising Efficacy and Market Potential of Spruce Biosciences’s Tildacerfontmarkets.businessinsider.com - December 6 at 7:46 PMWhat 4 Analyst Ratings Have To Say About Spruce Biosciencesmarkets.businessinsider.com - November 20 at 3:39 PMRBC Capital Reaffirms Their Buy Rating on Spruce Biosciences (SPRB)markets.businessinsider.com - November 15 at 10:56 AMSpruce Biosciences GAAP EPS of -$0.30 beats by $0.05msn.com - November 13 at 9:12 PMSpruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updatesfinance.yahoo.com - November 13 at 4:12 PMSpruce Biosciences to Participate in the Jefferies London Healthcare Conferencefinance.yahoo.com - November 2 at 8:29 PMBuy Rating Issued for Spruce Biosciences: Strong Trial Performance and Promising Future for Tildacerfontmarkets.businessinsider.com - October 19 at 10:54 AMSpruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal Hyperplasiafinance.yahoo.com - October 18 at 12:56 PMPromising Future for Spruce Biosciences: A Buy Rating Based on Successful Pediatric and Adult CAH Trialsmarkets.businessinsider.com - October 5 at 3:12 PM Get Spruce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRB and its competitors with MarketBeat's FREE daily newsletter. Email Address This 1 Biotech Stock has been shocking the markets (Ad)Save the Date: BioStem's 2024 Q1 Call Coming Up! Sign Up for the Live Broadcast here SPRB Media Mentions By Week SPRB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SPRB News Sentiment▼0.000.36▲Average Medical News Sentiment SPRB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SPRB Articles This Week▼01▲SPRB Articles Average Week Get Spruce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ImmunoPrecise Antibodies News Today Viracta Therapeutics News Today Fortress Biotech News Today Daré Bioscience News Today Acurx Pharmaceuticals News Today BriaCell Therapeutics News Today CASI Pharmaceuticals News Today Marker Therapeutics News Today Theratechnologies News Today Apollomics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SPRB) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spruce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
